The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway

The abnormally expressed long non-coding RNA (lncRNA) H19 has a crucial function in the development and progression of cardiovascular disease; however, its role in atherosclerosis is yet to be known. We aimed to examine the impacts of lncRNA H19 on atherogenesis as well as the involved mechanism. Th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shi-Feng Huang, Guifang Zhao, Xiao-Fei Peng, Wen-Chu Ye
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/3be4c4c9fceb480ebf2a28efd76a9210
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3be4c4c9fceb480ebf2a28efd76a9210
record_format dspace
spelling oai:doaj.org-article:3be4c4c9fceb480ebf2a28efd76a92102021-11-08T07:10:03ZThe Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway2297-055X10.3389/fcvm.2021.770163https://doaj.org/article/3be4c4c9fceb480ebf2a28efd76a92102021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.770163/fullhttps://doaj.org/toc/2297-055XThe abnormally expressed long non-coding RNA (lncRNA) H19 has a crucial function in the development and progression of cardiovascular disease; however, its role in atherosclerosis is yet to be known. We aimed to examine the impacts of lncRNA H19 on atherogenesis as well as the involved mechanism. The outcomes from this research illustrated that the expression of lncRNA H19 was elevated in mouse blood and aorta with lipid-loaded macrophages and atherosclerosis. Adeno-associated virus (AAV)-mediated lncRNA H19 overexpression significantly increased the atherosclerotic plaque area in apoE−/− mice supplied with a Western diet. The upregulation of lncRNA H19 decreased the miR-146a-5p expression but increased the levels of ANGPTL4 in mouse blood and aorta and THP-1 cells. Furthermore, lncRNA H19 overexpression promoted lipid accumulation in oxidized low-density lipoprotein (ox-LDL)-induced THP-1 macrophages. However, the knockdown of lncRNA H19 served as a protection against atherosclerosis in apoE−/− mice and lowered the accumulation of lipids in ox-LDL-induced THP-1 macrophages. lncRNA H19 promoted the expression of ANGPTL4 via competitively binding to miR-146a-5p, thus promoting lipid accumulation in atherosclerosis. These findings altogether demonstrated that lncRNA H19 facilitated the accumulation of lipid in macrophages and aggravated the progression of atherosclerosis through the miR-146a-5p/ANGPTL4 pathway. Targeting lncRNA H19 might be an auspicious therapeutic approach for preventing and treating atherosclerotic disease.Shi-Feng HuangGuifang ZhaoXiao-Fei PengWen-Chu YeFrontiers Media S.A.articlelncRNA H19atherosclerosismiR-146a-5pANGPTL4lipid accumulationDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic lncRNA H19
atherosclerosis
miR-146a-5p
ANGPTL4
lipid accumulation
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle lncRNA H19
atherosclerosis
miR-146a-5p
ANGPTL4
lipid accumulation
Diseases of the circulatory (Cardiovascular) system
RC666-701
Shi-Feng Huang
Guifang Zhao
Xiao-Fei Peng
Wen-Chu Ye
The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway
description The abnormally expressed long non-coding RNA (lncRNA) H19 has a crucial function in the development and progression of cardiovascular disease; however, its role in atherosclerosis is yet to be known. We aimed to examine the impacts of lncRNA H19 on atherogenesis as well as the involved mechanism. The outcomes from this research illustrated that the expression of lncRNA H19 was elevated in mouse blood and aorta with lipid-loaded macrophages and atherosclerosis. Adeno-associated virus (AAV)-mediated lncRNA H19 overexpression significantly increased the atherosclerotic plaque area in apoE−/− mice supplied with a Western diet. The upregulation of lncRNA H19 decreased the miR-146a-5p expression but increased the levels of ANGPTL4 in mouse blood and aorta and THP-1 cells. Furthermore, lncRNA H19 overexpression promoted lipid accumulation in oxidized low-density lipoprotein (ox-LDL)-induced THP-1 macrophages. However, the knockdown of lncRNA H19 served as a protection against atherosclerosis in apoE−/− mice and lowered the accumulation of lipids in ox-LDL-induced THP-1 macrophages. lncRNA H19 promoted the expression of ANGPTL4 via competitively binding to miR-146a-5p, thus promoting lipid accumulation in atherosclerosis. These findings altogether demonstrated that lncRNA H19 facilitated the accumulation of lipid in macrophages and aggravated the progression of atherosclerosis through the miR-146a-5p/ANGPTL4 pathway. Targeting lncRNA H19 might be an auspicious therapeutic approach for preventing and treating atherosclerotic disease.
format article
author Shi-Feng Huang
Guifang Zhao
Xiao-Fei Peng
Wen-Chu Ye
author_facet Shi-Feng Huang
Guifang Zhao
Xiao-Fei Peng
Wen-Chu Ye
author_sort Shi-Feng Huang
title The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway
title_short The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway
title_full The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway
title_fullStr The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway
title_full_unstemmed The Pathogenic Role of Long Non-coding RNA H19 in Atherosclerosis via the miR-146a-5p/ANGPTL4 Pathway
title_sort pathogenic role of long non-coding rna h19 in atherosclerosis via the mir-146a-5p/angptl4 pathway
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/3be4c4c9fceb480ebf2a28efd76a9210
work_keys_str_mv AT shifenghuang thepathogenicroleoflongnoncodingrnah19inatherosclerosisviathemir146a5pangptl4pathway
AT guifangzhao thepathogenicroleoflongnoncodingrnah19inatherosclerosisviathemir146a5pangptl4pathway
AT xiaofeipeng thepathogenicroleoflongnoncodingrnah19inatherosclerosisviathemir146a5pangptl4pathway
AT wenchuye thepathogenicroleoflongnoncodingrnah19inatherosclerosisviathemir146a5pangptl4pathway
AT shifenghuang pathogenicroleoflongnoncodingrnah19inatherosclerosisviathemir146a5pangptl4pathway
AT guifangzhao pathogenicroleoflongnoncodingrnah19inatherosclerosisviathemir146a5pangptl4pathway
AT xiaofeipeng pathogenicroleoflongnoncodingrnah19inatherosclerosisviathemir146a5pangptl4pathway
AT wenchuye pathogenicroleoflongnoncodingrnah19inatherosclerosisviathemir146a5pangptl4pathway
_version_ 1718442897335910400